Secondly, Mr Watts notes and shares his observations about the Consumer Advisory Committee and whether or not it is really being allowed a voice to be provided by consumers to Pharmac. I think the review report makes it pretty clear that, actually, Pharmac, in its decision making, has really—to be charitable—struggled to incorporate the input of the Consumer Advisory Committee and, indeed, other groups that they've set up like the rare disorders committee that they set up. That met infrequently, it didn't have somebody with lived experience on it—those sorts of things. So I think that's out now and that's recorded in the review. I think that's an area that does need to change, and we made it clear as a Government in our response that we needed to see change in that. Again, I'm confident that the way the health sector principles will apply to Pharmac will ensure that that will happen too. 